Suchergebnisse - "0377-8282" OR "2013-0368"

PubPharm (13.238)

111

Onvansertib fumarate. Serine/threonine-protein kinase, PLK1 (STPK13) inhibitor, Treatment of prostate cancer, Treatment of colorectal cancer, Treatment of acute myeloid leukemia

enthalten in: Drugs of the future | 2020

von Gras, J.

112

New antithrombotic strategies based on the inhibition of factor XI/XIa

enthalten in: Drugs of the future | 2020

von Zafar, M. | Badimon, J. | Escolar, G.

113

Trilaciclib hydrochloride. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor, Myelopreservation therapy, Treatment of small cell lung cancer, Treatment of triple-negative breast cancer

enthalten in: Drugs of the future | 2020

von Barquero, N.

114

Etrasimod arginine. Sphingosine-1-phosphate receptor 1 (S1P1 receptor) agonist, Treatment of ulcerative colitis

enthalten in: Drugs of the future | 2020

von Gras, J.

115

Centhaquine citrate. alpha2B-Adrenoceptor ligand, Resuscitative agent for hypovolemic shock

enthalten in: Drugs of the future | 2020

von Gulati, A. | Lavhale, M. | Giri, R. | +2

116

Rezafungin acetate. 1,3-beta-Glucan synthase inhibitor, Antifungal agent

enthalten in: Drugs of the future | 2020

von Chopra, S. | Thakare, R. | Dasgupta, A.

117

NME Digest - January 2020

enthalten in: Drugs of the future | 2020

von Bofill, X. | Cole, P. | Fernandez-Forner, D. | +1

118

Teprotumumab. Anti-insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, Treatment of thyroid eye disease

enthalten in: Drugs of the future | 2020

von Ferro Desideri, L. | Vagge, A. | del Noce, C. | +2

119

Pipeline on the Move - January 2020

enthalten in: Drugs of the future | 2020

von Torramade, E. | Molas, G. | Tell, M. | +1

120

Recent Clinical Disclosures and SMR Award. Highlights from The Society for Medicines Research Symposium. London, UK - December 5, 2019

enthalten in: Drugs of the future | 2020

von Brown, P. | Butterworth, S. | Hann, M. | +4